Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Deeks

Showing results (131-140 of 663) with videos related to

Pageof 67
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2005
The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infectionJoan C Lo, Mahmood R Kazemi, Priscilla Y Hsue, et al.
Antiviral Therapy|February 4, 2012
Increased CD34+/KDR+ cells are not associated with carotid artery intima-media thickness progression in chronic HIV-positive subjectsEmmanouil Papasavvas, Priscilla Hsue, Griffin Reynolds, et al.
Human Immunology|November 8, 2016
Psoriasis risk SNPs and their association with HIV-1 controlJoanne Nititham, Rashmi Gupta, Xue Zeng, et al.
Plos One|January 25, 2018
Viral protein Nef is detected in plasma of half of HIV-infected adults with undetectable plasma HIV RNAJana Ferdin, Katja Goričar, Vita Dolžan, et al.
Journal of Virus Eradication|November 9, 2019
Statistical analysis of single-copy assays when some observations are zeroPeter Bacchetti, Ronald J Bosch, Eileen P Scully, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 26, 2008
Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infectionElizabeth Sinclair, Rollie Ronquillo, Nicole Lollo, et al.
Journal of Virology|March 21, 2008
HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus controlBrinda Emu, Elizabeth Sinclair, Hiroyu Hatano, et al.
AIDS (London, England)|October 4, 2008
Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modificationMaya L Petersen, Mark J van der Laan, Sonia Napravnik, et al.
Journal of Virology|January 21, 2011
Reappraisal of the relationship between the HIV-1-protective single-nucleotide polymorphism 35 kilobases upstream of the HLA-C gene and surface HLA-C expressionTumena W Corrah, Nilu Goonetilleke, Jakub Kopycinski, et al.
AIDS (London, England)|May 21, 2005
Perinatal transmission of multidrug-resistant HIV-1 despite viral suppression on an enfuvirtide-based treatment regimenDeborah Cohan, Cynthia Feakins, Diane Wara, et al.
Pageof 67

Showing results (131-140 of 663) with videos related to

Sort By:
Pageof 67
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2005
The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infectionJoan C Lo, Mahmood R Kazemi, Priscilla Y Hsue, et al.
Antiviral Therapy|February 4, 2012
Increased CD34+/KDR+ cells are not associated with carotid artery intima-media thickness progression in chronic HIV-positive subjectsEmmanouil Papasavvas, Priscilla Hsue, Griffin Reynolds, et al.
Human Immunology|November 8, 2016
Psoriasis risk SNPs and their association with HIV-1 controlJoanne Nititham, Rashmi Gupta, Xue Zeng, et al.
Plos One|January 25, 2018
Viral protein Nef is detected in plasma of half of HIV-infected adults with undetectable plasma HIV RNAJana Ferdin, Katja Goričar, Vita Dolžan, et al.
Journal of Virus Eradication|November 9, 2019
Statistical analysis of single-copy assays when some observations are zeroPeter Bacchetti, Ronald J Bosch, Eileen P Scully, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 26, 2008
Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infectionElizabeth Sinclair, Rollie Ronquillo, Nicole Lollo, et al.
Journal of Virology|March 21, 2008
HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus controlBrinda Emu, Elizabeth Sinclair, Hiroyu Hatano, et al.
AIDS (London, England)|October 4, 2008
Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modificationMaya L Petersen, Mark J van der Laan, Sonia Napravnik, et al.
Journal of Virology|January 21, 2011
Reappraisal of the relationship between the HIV-1-protective single-nucleotide polymorphism 35 kilobases upstream of the HLA-C gene and surface HLA-C expressionTumena W Corrah, Nilu Goonetilleke, Jakub Kopycinski, et al.
AIDS (London, England)|May 21, 2005
Perinatal transmission of multidrug-resistant HIV-1 despite viral suppression on an enfuvirtide-based treatment regimenDeborah Cohan, Cynthia Feakins, Diane Wara, et al.
Pageof 67